首站-论文投稿智能助手
典型文献
Regulation of innate immune responses by rabies virus
文献摘要:
Rabies virus (RABV) is an infectious and neurotropic pathogen that causes rabies and infects humans and almost all warm-blooded animals, posing a great threat to people and public safety. It is well known that innate immunity is the critical first line of host defense against viral infection. It monitors the invading pathogens by recognizing the pathogen-associated molecular patterns and danger-associated molecular patterns through pattern-recognition receptors, leading to the production of type I interferons (IFNα/β), inflammatory cytokines, and chemokines, or the activation of autophagy or apoptosis to inhibit virus replication. In the case of RABV, the innate immune response is usually triggered when the skin or muscle is bitten or scratched. However, RABV has evolved many ways to escape or even hijack innate immune response to complete its own replication and eventually invades the central nervous system (CNS). Once RABV reaches the CNS, it cannot be wiped out by the immune system or any drugs. Therefore, a better understanding of the interplay between RABV and innate immu-nity is necessary to develop effective strategies to combat its infection. Here, we review the innate immune responses induced by RABV and illustrate the antagonism mechanisms of RABV to provide new insights for the control of rabies.
文献关键词:
作者姓名:
Haili Zhang;Jingbo Huang;Yumeng Song;Xingqi Liu;Meichen Qian;Pei Huang;Yuanyuan Li;Ling Zhao;Hualei Wang
作者机构:
State Key Laboratory for Zoonotic Diseases,Key Laboratory for Zoonosis Research of the Ministry of Education,Institute of Zoonosis,and College of Veterinary Medicine,Jilin University,Changchun,China;State Key Laboratory of Agricultural Microbiology,Huazhong Agricultural University,Wuhan,China
引用格式:
[1]Haili Zhang;Jingbo Huang;Yumeng Song;Xingqi Liu;Meichen Qian;Pei Huang;Yuanyuan Li;Ling Zhao;Hualei Wang-.Regulation of innate immune responses by rabies virus)[J].动物模型与实验医学(英文),2022(05):418-429
A类:
blooded,bitten,hijack,wiped
B类:
Regulation,innate,immune,responses,by,rabies,virus,Rabies,RABV,infectious,neurotropic,that,causes,infects,humans,almost,warm,animals,posing,great,threat,people,public,safety,It,well,known,immunity,critical,first,line,host,defense,against,viral,infection,monitors,invading,pathogens,recognizing,associated,molecular,patterns,danger,through,recognition,receptors,leading,production,type,interferons,IFN,inflammatory,cytokines,chemokines,activation,autophagy,apoptosis,inhibit,replication,In,case,usually,triggered,when,skin,muscle,scratched,However,has,evolved,many,ways,escape,complete,its,eventually,invades,central,nervous,system,CNS,Once,reaches,cannot,out,drugs,Therefore,better,understanding,interplay,between,necessary,develop,effective,strategies,combat,Here,review,induced,illustrate,antagonism,mechanisms,provide,new,insights,control
AB值:
0.565286
相似文献
HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
Li Shuang;Moog Christiane;Zhang Tong;Su Bin-Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Laboratoire d' ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg 67000, France
Regulation of innate and adaptive immunity using herbal medicine: benefits for the COVID-19 vaccination
Xuan Li;Nuttapong Wichai;Jiabao Wang;Xiuping Liu;Huimin Yan;Yu Wang;Mingchi Luo;Shengyuan Zhou;Kai Wang;Lin Li;Lin Miao-State Key Laboratory of Component-based Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin,China;Institute of Traditional Chinese Medicine,Tianjin University ofTraditional Chinese Medicine,Tianjin,China;Faculty of Pharmacy,Mahasarakham University,Mahasarakham,Thailand;Institute of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin,China;Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae,Ministry of Education,Tianjin University of Traditional Chinese Medicine,Tianjin,China;Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice
Qiu-yan Zhang;Su-jing Xu;Jian-chang Qian;Li-bin Yang;Peng-qin Chen;Yi Wang;Xiang Hu;Ya-li Zhang;Wu Luo;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Medical Research Center,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School and Hospital of Stomatology,Wenzhou Medical University,Wenzhou 325027,China;Department of Endocrinology,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury
Chao Deng;Lin Zhao;Zhi Yang;Jia-jia Shang;Chang-yu Wang;Ming-zhi Shen;Shuai Jiang;Tian Li;Wen-cheng Di;Ying Chen;He Li;Ye-dong Cheng;Yang Yang-Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases,Xi'an No.3 Hospital,School of Life Sciences and Medicine,Northwest University,Xi'an 710021,China;Department of Orthopaedics,Huaian Medical District of Jingling Hospital,Medical School of Nanjing University,Huaian 213001,China;Department of Cardiovascular Surgery,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China;Department of Cardiovascular Surgery,Xijing Hospital,The Fourth Military Medical University,Xi'an 710032,China;Key Laboratory of Resource Biology and Biotechnology in Western China,Ministry of Education.Life of Sciences,Northwest University,Xi'an 710021,China;Department of Cardiology,Xi'an No.3 Hospital,School of Life Sciences and Medicine,Northwest University,Xi'an 710021,China;Hainan Hospital of PLA General Hospital,The Second School of Clinical Medicine,Southern Medical University,Sanya 572013,China;National Clinical Research Center for Infectious Diseases,Shenzhen Third People's Hospital,Southern University of Science and Technology,Shenzhen 518100,China;Department of Hematology,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。